DE:HHB0 Stock Latest News
Company AnnouncementsXTL Biopharmaceuticals Moves to Replace Resigning External Director2w ago6KXTLB
Company AnnouncementsXTL Biopharmaceuticals Faces Derivative Action Bid Over Failed Social Proxy Acquisition2M ago6KXTLB
Company AnnouncementsXTL Biopharmaceuticals Regains Nasdaq Compliance and Enters One-Year Monitoring Period3M ago6KXTLB
Company AnnouncementsXTL Biopharmaceuticals Completes Psyga Bio Acquisition, Refocuses on Psychedelic Medicine4M ago6KXTLB
Company AnnouncementsXTL Biopharmaceuticals Shareholders Approve Psyga Bio Acquisition and Major Capital Increase4M ago6KXTLB
Company AnnouncementsXTL Biopharmaceuticals Adjourns Extraordinary Shareholder Meeting to June 29, 20264M ago6KXTLBCompany AnnouncementsXTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report5M ago6KXTLB
Company AnnouncementsXTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise5M ago6KXTLB
Company AnnouncementsXTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal5M ago6KXTLB
Company AnnouncementsXTL Biopharmaceuticals Delays 20-F Amid Subsidiary Liquidation6M agoXTLB- Company AnnouncementsXTL Biopharmaceuticals to Acquire PsygaBio in All-Stock Deal to Expand Psychedelic Drug Pipeline6M ago6KXTLB
- The FlyXTL Biopharmaceuticals to acquire Psyga Bio6M agoXTLB